Published in J Virol on December 01, 1996
cis-Acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus. J Virol (1997) 1.44
Base pairing among three cis-acting sequences contributes to template switching during hepadnavirus reverse transcription. Proc Natl Acad Sci U S A (2003) 1.12
Base pairing between cis-acting sequences contributes to template switching during plus-strand DNA synthesis in human hepatitis B virus. J Virol (2007) 1.11
Analysis of duck hepatitis B virus reverse transcription indicates a common mechanism for the two template switches during plus-strand DNA synthesis. J Virol (2002) 1.01
Characterization of the cis-acting contributions to avian hepadnavirus RNA encapsidation. J Virol (2002) 0.98
Mutations that increase in situ priming also decrease circularization for duck hepatitis B virus. J Virol (2001) 0.95
cis-Acting sequences 5E, M, and 3E interact to contribute to primer translocation and circularization during reverse transcription of avian hepadnavirus DNA. J Virol (2002) 0.93
cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses. J Virol (2010) 0.82
Changing the site of initiation of plus-strand DNA synthesis inhibits the subsequent template switch during replication of a hepadnavirus. J Virol (1998) 0.82
Genomic sequencing. Proc Natl Acad Sci U S A (1984) 92.36
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell (1982) 16.71
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J Virol (1984) 8.32
Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell (1986) 6.12
Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription. Nature (1990) 5.68
The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol (1990) 5.19
Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol (1990) 4.57
Novel mechanism for reverse transcription in hepatitis B viruses. J Virol (1993) 4.47
Transcripts and the putative RNA pregenome of duck hepatitis B virus: implications for reverse transcription. Cell (1985) 4.41
Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res (1987) 3.83
Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol (1990) 3.53
Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol (1986) 3.46
Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol (1991) 3.26
Isolation and characterization of a hepatitis B virus endemic in herons. J Virol (1988) 3.23
Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting. Nature (1989) 3.10
Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J Virol (1994) 3.05
Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J Virol (1994) 2.98
Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J Virol (1987) 2.89
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol (1994) 2.69
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J Virol (1991) 2.66
The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging. J Virol (1989) 2.47
Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation. J Virol (1994) 2.38
Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase. J Virol (1990) 2.22
Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements. EMBO J (1991) 2.17
Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol (1994) 2.10
Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA. Virology (1988) 2.03
Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses. J Virol (1994) 1.87
Transfer of the minus strand of DNA during hepadnavirus replication is not invariable but prefers a specific location. J Virol (1995) 1.43
The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses. Proc Natl Acad Sci U S A (1995) 1.35
Duck hepatitis B virus can tolerate insertion, deletion, and partial frameshift mutation in the distal pre-S region. J Virol (1989) 1.23
The sequence of a large L1Md element reveals a tandemly repeated 5' end and several features found in retrotransposons. Mol Cell Biol (1986) 4.83
Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science (1987) 3.46
Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol (1991) 3.26
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J Virol (1991) 2.66
Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res Hum Retroviruses (1989) 2.62
Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem (1991) 2.11
Conservation throughout mammalia and extensive protein-encoding capacity of the highly repeated DNA long interspersed sequence one. J Mol Biol (1986) 1.93
Nucleotide sequence of the BALB/c mouse beta-globin complex. J Mol Biol (1989) 1.47
cis-Acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus. J Virol (1997) 1.44
Determination of a functional ancestral sequence and definition of the 5' end of A-type mouse L1 elements. J Mol Biol (1987) 1.41
Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants. Proc Natl Acad Sci U S A (1997) 1.17
Complete mutagenesis of protein coding domains. Methods Enzymol (1991) 1.16
Transposition of a long member of the L1 major interspersed DNA family into the mouse beta globin gene locus. Nucleic Acids Res (1985) 1.11
The L1 family in mice. Prog Clin Biol Res (1987) 0.97
A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant. Virology (1995) 0.96
Identification of temperature-sensitive mutants of the human immunodeficiency virus type 1 protease through saturation mutagenesis. Amino acid side chain requirements for temperature sensitivity. J Biol Chem (1994) 0.90
The molecular organization of the beta-globin complex of the deer mouse, Peromyscus maniculatus. Mol Biol Evol (1987) 0.84
L1 gene conversion or same-site transposition. Mol Biol Evol (1991) 0.82
Insertions within epsilon affect synthesis of minus-strand DNA before the template switch for duck hepatitis B virus. J Virol (1997) 0.80
A directed nucleotide-sequencing approach for single-stranded vectors based on recloning intermediates of a progressive DNA synthesis reaction. Gene (1988) 0.80
Analysis of temperature-sensitive mutants of the HIV-1 protease. Adv Exp Med Biol (1991) 0.76